Hyogo Cancer Center ( Site 0656)

Akashi, Hyōgo 673-8558

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Neoplasms

Studies at this site

• Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) — Running, not enrolling